Lanzamiento Enero 2027

Ensayo controlado aleatorizado2012Financiación no declarada

Genetic determinants of blood pressure responses to caffeine drinking

Renda G, Zimarino M, Antonucci I, Tatasciore A, Ruggieri B, Bucciarelli T, Prontera T, Stuppia L, De Caterina R

The American journal of clinical nutrition · 42 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2011-12-15 · Am J Clin Nutr · vol. 95 · número 1 · págs. 241–248
Editorial
Elsevier BV
Citado
69 citas · más que el 84% de estudios similares · 1.9× el promedio de su campo
Referencias
52 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Coffee research and impacts · Blood Pressure and Hypertension Studies · Genetic Associations and Epidemiology
Palabras clave
caffeine, blood pressure response, coffee consumption, genetic polymorphism, adenosine A2A receptor, ADRA2B, alpha2-adrenoceptors, caffeine metabolism, catecholamines, epinephrine, ambulatory blood pressure monitoring
MeSH
humans, epinephrine, caffeine, receptors, adrenergic, alpha-2, receptor, adenosine a2a, adenosine, plant extracts, blood pressure monitoring, ambulatory, double-blind method, blood pressure, polymorphism, genetic, coffee, adult, male, young adult

9 autores

  • Giulia Renda🇮🇹University of Chieti-Pescara
  • Marco Zimarino🇮🇹University of Chieti-Pescara
  • Ivana Antonucci🇮🇹University of Chieti-Pescara
  • Alfonso Tatasciore🇮🇹University of Chieti-Pescara
  • Benedetta Ruggieri🇮🇹University of Chieti-Pescara
  • Tonino Bucciarelli🇮🇹University of Chieti-Pescara
  • Tina Prontera🇮🇹University of Chieti-Pescara
  • Liborio Stuppia🇮🇹University of Chieti-Pescara
  • Raffaele De Caterina🇮🇹University of Chieti-Pescara

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

The widely observed between-subject variability in cardiovascular responses to coffee may have a genetic basis.

Objective

We evaluated acute blood pressure (BP) responses to caffeine and explored whether they are influenced by candidate gene variants affecting caffeine metabolism (for cytochrome P450 1A2), adenosine metabolism (for adenosine receptor and AMP deaminase), or catecholamine receptors.

Methods

We recruited 110 healthy male habitual moderate coffee drinkers who refrained from drinking coffee on the day preceding the study. Each subject underwent ambulatory BP monitoring at 6-min intervals for 2 h. Each participant was administered, in a double-blind design, 40 mL of either a decaffeinated coffee preparation plus 3 mg caffeine/kg (caf) or the corresponding vehicle (decaf). The protocol was repeated 24 h later with the alternative preparation. Blood samples were collected for genetic and plasma caffeine and catecholamine evaluations.

Results

Compared with decaf, caf was associated with a mean (± SD) significant increase in systolic BP of 4 ± 12 mm Hg and in diastolic BP of 3 ± 10 mm Hg (P < 0.001 for both). Plasma caffeine and adrenaline increased after caf, but not after decaf. Of 11 gene polymorphisms analyzed, a relation was observed between the ADORA2A TT variant and the change in SBP peak and between the ADRA2B I variant and the changes in both SBP mean and peak; mean peak change in SBP; these variants were associated with increased SBP responses to caf.

Conclusions

Variability in the acute BP response to coffee may be partly explained by genetic polymorphisms of the adenosine A2A receptors and α(2)-adrenergic receptors. This trial is registered at clinicaltrials.gov as NCT01330680.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.